Discover the IQVIA NTB Forecast White Paper 2024, which introduces a groundbreaking methodology for pharmaceutical forecasting focused on new patient acquisition. Learn how the NTB Forecast achieves over 90% accuracy, transforming launch planning and strategic decision-making in the dynamic pharmaceutical market. Through case studies and detailed analysis, the white paper showcases the NTB Forecast's ability to transform launch planning and drive strategic decision-making, ultimately improving patient outcomes and market performance.